Related Experiment Video
Updated: Aug 13, 2025
Psychophysically-anchored, Robust Thresholding in Studying Pain-related Lateralization of Oscillatory Prestimulus Activity
Published on: January 21, 2017
Does baseline EEG activity differ in the transition to or from a chronic pain state? A longitudinal study
Britt B Schuurman1, Catherine J Vossen2,3, Therese A M J van Amelsvoort1
1Department of Psychiatry & Neuropsychology, Faculty of Health Medicine and Life Sciences, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.
Developing chronic pain is associated with decreased alpha power in resting-state electroencephalography (EEG). Conversely, transitioning to a pain-free state shows increased alpha power, confirming the link between brain activity and pain status.
Area of Science:
- Neuroscience
- Pain Research
- Biomedical Engineering
Background:
- Chronic pain development lacks clear mechanistic understanding.
- Electroencephalography (EEG) may offer insights into pain pathophysiology.
- This study investigated EEG markers associated with pain state transitions.
Purpose of the Study:
- To determine if changes in resting-state EEG alpha power correlate with the development or resolution of chronic pain.
- To explore EEG as a potential biomarker for chronic pain states.
Main Methods:
- Longitudinal resting-state EEG (eyes open) recorded from 95 subjects at baseline and 6-month follow-up.
- Subjects categorized into four pain groups: pain-free, developing pain, becoming pain-free, and ongoing pain.
- Multilevel regression analysis applied to EEG data from 14 electrodes.
Main Results:
- Subjects developing chronic pain showed reduced lower-frequency band power over time.
- Individuals transitioning to a pain-free state exhibited the opposite EEG pattern.
- The findings support the hypothesis linking EEG activity changes to pain state transitions.
Conclusions:
- Baseline EEG activity significantly changes with transitions in chronic pain states.
- These findings may inform the development of neurofeedback therapies for chronic pain.
- Replication in larger, diverse clinical populations is warranted.
